Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

West Pharmaceutical Services shares have dropped 35% in 2025, despite better-than-expected Q1 results, with forward guidance ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

The global Electronic Lab Notebook Market, valued at US$0.68 billion in 2024 stood at US$0.72 billion in 2025 and is projected to advance at ...

Báo điện tử VOV, tin tức thời sự về chính trị, kinh tế, đời sống, xã hội, pháp luật, thể thao, văn hóa, giải trí, thế giới, ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

CM, offers strong efficacy and a favorable safety profile compared to competitors. See why I rate ALNY stock a Hold.

Many FDA-regulated companies are exploring ways to support diagnostic testing, especially when early diagnosis can impact treatment options.

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the ...

Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...